These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33989752)

  • 1. Long-acting implantable dosage forms containing paliperidone palmitate obtained by 3D printing.
    Manini G; Deldime M; Benali S; Raquez JM; Goole J
    Int J Pharm; 2021 Jun; 603():120702. PubMed ID: 33989752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application.
    Manini G; Benali S; Mathew A; Napolitano S; Raquez JM; Goole J
    Int J Pharm; 2022 Apr; 618():121662. PubMed ID: 35292399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of concept of a predictive model of drug release from long-acting implants obtained by fused-deposition modeling.
    Manini G; Benali S; Raquez JM; Goole J
    Int J Pharm; 2022 Apr; 618():121663. PubMed ID: 35292398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
    Funk NL; Fantaus S; Beck RCR
    Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs.
    Picco CJ; Domínguez-Robles J; Utomo E; Paredes AJ; Volpe-Zanutto F; Malinova D; Donnelly RF; Larrañeta E
    Drug Deliv; 2022 Dec; 29(1):1038-1048. PubMed ID: 35363100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
    Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension.
    Darville N; van Heerden M; Mariën D; De Meulder M; Rossenu S; Vermeulen A; Vynckier A; De Jonghe S; Sterkens P; Annaert P; Van den Mooter G
    J Control Release; 2016 May; 230():95-108. PubMed ID: 27067365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion.
    Jamróz W; Kurek M; Czech A; Szafraniec J; Gawlak K; Jachowicz R
    Eur J Pharm Biopharm; 2018 Oct; 131():44-47. PubMed ID: 30048746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants.
    Kempin W; Franz C; Koster LC; Schneider F; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2017 Jun; 115():84-93. PubMed ID: 28232106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive overview of extended release oral dosage forms manufactured through hot melt extrusion and its combination with 3D printing.
    Nashed N; Lam M; Nokhodchi A
    Int J Pharm; 2021 Mar; 596():120237. PubMed ID: 33484928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
    Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
    Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocrystal-based 3D-printed tablets: Semi-solid extrusion using melting solidification printing process (MESO-PP) for oral administration of poorly soluble drugs.
    Lopez-Vidal L; Real JP; Real DA; Camacho N; Kogan MJ; Paredes AJ; Palma SD
    Int J Pharm; 2022 Jan; 611():121311. PubMed ID: 34813905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D printing in the design of pharmaceutical dosage forms.
    Souto EB; Campos JC; Filho SC; Teixeira MC; Martins-Gomes C; Zielinska A; Carbone C; Silva AM
    Pharm Dev Technol; 2019 Oct; 24(8):1044-1053. PubMed ID: 31180272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.